Aspen Declares Dividends on Preference Shares

Aspen Declares Dividends on Preference Shares

HAMILTON, Bermuda–(BUSINESS WIRE)–
Aspen Insurance Holdings Limited (“Aspen”) (NYSE:AHL) announced today that the Board of Directors has declared the following dividends on its Preference Shares:

  • Quarterly dividend of $0.3719 per share on its 5.95% Fixed-to-Floating Rate Perpetual Non-Cumulative Preference Shares with a $25 liquidation preference per share (NYSE:AHL PRC);
  • Quarterly dividend of $0.3516 per share on its 5.625% Perpetual Non-Cumulative Preference Shares with a $25 liquidation preference per share (NYSE:AHL PRD); and
  • Quarterly dividend of $351.56 per share on its 5.625% Perpetual Non-Cumulative Preference Shares with a liquidation preference of $25,000 per share, represented by depositary shares (NYSE: AHL PRE), each representing a 1/1000th interest in a share, holders of which depositary shares will receive $0.35156 per depositary share.

The above dividends will be payable on April 1, 2021 to holders of record as of March 15, 2021.

About Aspen Insurance Holdings Limited

Aspen provides reinsurance and insurance coverage to clients in various domestic and global markets through wholly-owned subsidiaries and offices in Australia, Bermuda, Canada, Singapore, Switzerland, the United Kingdom and the United States. For the year ended December 31, 2019, Aspen reported $12.6 billion in total assets, $7.0 billion in gross reserves, $2.7 billion in total shareholders’ equity and $3.4 billion in gross written premiums. Aspen’s operating subsidiaries have been assigned a rating of “A-” by Standard & Poor’s Financial Services LLC, and an “A” (“Excellent”) by A.M. Best Company Inc. For more information about Aspen, please visit www.aspen.co.

Cautionary Statement Regarding Forward-Looking Statements

This communication and other written or oral statements made by or on behalf of Aspen contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that are made under the “safe harbor” provisions of The Private Securities Litigation Reform Act of 1995. In particular, statements using words such as “may,” “seek,” “will,” “likely,” “assume,” “estimate,” “expect,” “anticipate,” “intend,” “believe,” “do not believe,” “aim,” “predict,” “plan,” “project,” “continue,” “potential,” “guidance,” “objective,” “outlook,” “trends,” “future,” “could,” “would,” “should,” “target,” “on track” or their negatives or variations, and similar terminology and words of similar import, generally involve future or forward-looking statements. Forward-looking statements reflect Aspen’s current views, plans or expectations with respect to future events and financial performance. They are inherently subject to significant business, economic, competitive and other risks, uncertainties and contingencies. The inclusion of forward-looking statements in this or any other communication should not be considered as a representation by Aspen or any other person that current plans or expectations will be achieved. Forward-looking statements speak only as of the date on which they are made, and Aspen undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future developments or otherwise, except as otherwise required by law.

There are or will be important factors that could cause actual results to differ materially from those expressed in any such forward-looking statements, including, but not limited to, factors affecting future results disclosed in Aspen’s filings with the SEC, including but not limited to those discussed under Item 3D, “Risk Factors” in Aspen’s Annual Report on Form 20-F for the year ended December 31, 2019, each of which is incorporated herein by reference.

Peter Krinks

Senior Group Communications Manager

[email protected]

+44 (0)20 7184 8544

KEYWORDS: Bermuda Caribbean

INDUSTRY KEYWORDS: Insurance Professional Services

MEDIA:

Logo
Logo

NORCAL Mutual Begins Solicitation of Policyholders in Proposed Demutualization

NORCAL Mutual Begins Solicitation of Policyholders in Proposed Demutualization

BIRMINGHAM, Ala.–(BUSINESS WIRE)–
The Board of Directors of NORCAL Mutual (“NORCAL”) has begun solicitation of policyholders to vote on NORCAL’s plan to convert from a mutual company to a stock company and to elect the form of payment they wish to receive if the conversion occurs.

On February 20, 2020 ProAssurance Corporation (NYSE: PRA) and the NORCAL Group announced the signing of a definitive agreement under which NORCAL would become a part of ProAssurance in a $450 million transaction following its demutualization. The demutualization and the acquisition agreement are mutually contingent, and are subject to required regulatory and policyholder approvals.

As part of this process, ProAssurance’s transfer agent Computershare has mailed documentation and materials to NORCAL’s eligible policyholders. Further, ProAssurance has begun solicitation of policyholders who elect to receive NORCAL stock in the conversion, asking them to respond to our tender offer and agree to sell those shares to us on the terms of the offer. Policyholders who elect NORCAL stock and tender it to ProAssurance will receive their allocated share of the $450 million cash transaction proceeds and will be eligible for a share of Contingent Consideration in an amount of up to $150 million depending upon development of NORCAL’s ultimate net losses between December 31, 2020 and December 31, 2023.

Eligible NORCAL policyholders may visit https://norcalconversion.com using login credentials provided in the documents mailed by Computershare, wherein they will be able to cast their vote on NORCAL’s Plan of Conversion and elect their desired form of payment.

The general public may visit https://www.norcal-group.com/pra for copies of documents and more information about the proposed transaction.

About ProAssurance

ProAssurance Corporation is an industry-leading specialty insurer with extensive expertise in healthcare professional liability, products liability for medical technology and life sciences, legal professional liability, and workers’ compensation insurance. ProAssurance Group is rated “A” (Excellent) by AM Best; ProAssurance and its operating subsidiaries are rated “A-” (Strong) by Fitch Ratings. For the latest on ProAssurance and its industry-leading suite of products and services, cutting-edge risk management and practice enhancement programs, follow @ProAssurance on Twitter or LinkedIn. ProAssurance’s YouTube channel regularly presents thought provoking, insightful videos that communicate effective practice management, patient safety and risk management strategies.

About NORCAL Group

The NORCAL Group of companies provide medical professional liability insurance, risk management solutions and provider wellness resources to physicians, healthcare extenders, medical groups, hospitals, community clinics, and allied healthcare facilities throughout the country. They share an AM Best “A-” (Excellent) rating for their financial strength and stability. NORCAL Group includes NORCAL Mutual Insurance Company and its affiliated insurance companies.

Transaction Advisors

ProAssurance is being advised in this transaction by Goldman Sachs & Co., LLC and the law firms of Burr & Forman, LLP and Sidley Austin, LLP. NORCAL is being advised by Waller Helms Advisors and the law firms of Mayer Brown, LLP, and McDermott Will & Emery, LLP.

Caution Regarding Forward-Looking Statements

Statements in this news release that are not historical fact or that convey our view of future business, events or trends are specifically identified as forward-looking statements. Forward-looking statements are based upon our estimates and anticipation of future events and highlight certain risks and uncertainties that could cause actual results to vary materially from our expected results. We expressly claim the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, for any forward-looking statements in this news release. Forward-looking statements represent our outlook only as of the date of this news release. Except as required by law or regulation, we do not undertake and specifically decline any obligation to publicly release the result of any revisions that may be made to any forward-looking statements to reflect events or circumstances after the date of such statements or to reflect the occurrence of anticipated or unanticipated events.

There are a number of risk factors that may cause outcomes that differ from our expectations or projections. These are described in detail in various documents filed by ProAssurance Corporation with the Securities and Exchange Commission, such as current reports on Form 8-K, and regular reports on Forms 10-Q and 10-K, particularly in “Item 1A, Risk Factors.”

Ken McEwen

Manager, Investor Relations

800-282-6242 • 205-439-7903 • [email protected]

KEYWORDS: United States North America Alabama

INDUSTRY KEYWORDS: Professional Services Health Insurance Practice Management Finance General Health

MEDIA:

Logo
Logo

Horace Mann Increases Quarterly Dividend by More Than 3%

Horace Mann Increases Quarterly Dividend by More Than 3%

SPRINGFIELD, Ill.–(BUSINESS WIRE)–
Horace Mann Educators Corporation (NYSE:HMN) today announced that its Board of Directors approved a 3.3% increase in the quarterly cash dividend to $0.31 per share. This represents an indicated annual dividend of $1.24 per share.

“Horace Mann is committed to driving long-term shareholder value creation,” said Marita Zuraitis, Horace Mann President and CEO. “This is the 13th consecutive year the Board has increased the annual shareholder cash dividend. In addition, we continue to opportunistically repurchase shares, buying almost 40,000 shares in February at a total cost of approximately $1.5 million.

“We will continue to drive shareholder value through execution of our strategic initiatives. As previously disclosed, we expect 2021 core earnings per share in the range of $3.00 to $3.20,” added Zuraitis. “Our primary use of the capital we generate will continue to be to support business growth at returns that meet or exceed our return on equity targets.”

The quarterly dividend is payable on March 31, 2021, to shareholders of record as of March 17, 2021.

About Horace Mann

Horace Mann is the largest financial services company focused on providing America’s educators and school employees with insurance and retirement solutions. Founded by Educators for Educators® in 1945, the company is headquartered in Springfield, Ill. For more information, visit horacemann.com.

Safe Harbor Statement

Statements included in this news release that are not historical in nature are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995 and are subject to certain risks and uncertainties. Horace Mann is not under any obligation to (and expressly disclaims any such obligation to) update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Please refer to the company’s Annual Report on Form 10-K for the period ended December 31, 2020 and the company’s past and future filings and reports filed with the Securities and Exchange Commission for information concerning the important factors that could cause actual results to differ materially from those in forward-looking statements.

Heather J. Wietzel

Vice President, Investor Relations

217-788-5144

[email protected]

KEYWORDS: Illinois United States North America

INDUSTRY KEYWORDS: Finance Other Education Professional Services Insurance Education

MEDIA:

Logo
Logo

Arcosa, Inc. Declares Quarterly Dividend

Arcosa, Inc. Declares Quarterly Dividend

DALLAS–(BUSINESS WIRE)–
Arcosa, Inc. (NYSE: ACA) (“Arcosa” or the “Company”), a provider of infrastructure-related products and solutions, today announced that its Board of Directors has declared a regular quarterly cash dividend of $0.05 per share on its $0.01 par value common stock. The quarterly cash dividend is payable April 30, 2021 to stockholders of record as of April 15, 2021.

About Arcosa

Arcosa, Inc. (NYSE:ACA), headquartered in Dallas, Texas, is a provider of infrastructure-related products and solutions with leading positions in construction, engineered structures, and transportation markets. Arcosa reports its financial results in three principal business segments: the Construction Products segment, the Engineered Structures segment, and the Transportation Products segment. For more information, visit www.arcosa.com.

INVESTOR CONTACTS

Scott C. Beasley

Chief Financial Officer

Gail M. Peck

SVP, Finance & Treasurer

T 972.942.6500

[email protected]

David Gold

ADVISIRY Partners

T 212.661.2220

[email protected]

MEDIA CONTACT

[email protected]

KEYWORDS: Texas United States North America

INDUSTRY KEYWORDS: Other Transport Construction & Property Rail Engineering Transport Oil/Gas Manufacturing Energy Other Construction & Property

MEDIA:

Cherry Hill Mortgage Investment Corporation Announces Common and Preferred Dividends for the First Quarter 2021

Cherry Hill Mortgage Investment Corporation Announces Common and Preferred Dividends for the First Quarter 2021

FARMINGDALE, N.J.–(BUSINESS WIRE)–
Cherry Hill Mortgage Investment Corporation (NYSE: CHMI) today announced that its Board of Directors has declared a dividend of $0.27 per share on the Company’s common stock for the first quarter of 2021. The dividend will be payable in cash on April 27, 2021 to holders of the common stock of record as of the close of business on March 31, 2021.

Additionally, Cherry Hill announced that its Board of Directors has declared a dividend of $0.5125 per share on the Company’s 8.20% Series A Cumulative Redeemable Preferred Stock and a dividend of $0.515625 per share on the Company’s 8.250% Series B Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock for the first quarter of 2021. The dividends will be payable in cash on April 15, 2021 to holders of the applicable Series of Preferred Stock of record as of the close of business on March 31, 2021.

About Cherry Hill Mortgage Investment Corporation

Cherry Hill Mortgage Investment Corporation is a real estate finance company that acquires, invests in and manages residential mortgage assets in the United States. For additional information, visit www.chmireit.com.

Forward-Looking Statements

This press release contains forward looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and other federal securities laws, including, among others, statements relating to the Company’s long-term growth opportunities and strategies, and its ability to generate sustainable and attractive risk-adjusted returns for stockholders. These forward looking statements are based upon the Company’s present expectations, but these statements are not guaranteed to occur. For a description of factors that may cause the Company’s actual results or performance to differ from its forward-looking statements, please review the information under the heading “Risk Factors” included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019, and other documents filed by the Company with the Securities and Exchange Commission.

Investor Relations

(877) 870 – 7005

[email protected]

KEYWORDS: United States North America New Jersey

INDUSTRY KEYWORDS: Residential Building & Real Estate Construction & Property Professional Services Finance

MEDIA:

Summit Materials to Host Virtual Investor Day

Summit Materials to Host Virtual Investor Day

DENVER–(BUSINESS WIRE)–Summit Materials, Inc. (NYSE: SUM, “Summit” or the “Company”), a leading vertically integrated construction materials company, today announced that it will host a virtual investor day to discuss its strategic outlook on Tuesday, March 16, 2021, at 11:00 a.m. mountain time (1:00 p.m. eastern time). The event will include a presentation and a question and answer session and will conclude at approximately 1:00 p.m. (3:00 p.m. eastern time).

A webcast will be available in the Investors section of Summit’s website at investors.summit-materials.com and at the following link: https://event.on24.com/wcc/r/3047237/EAB93CC2BB75B482029053E73C71BE0B.

You will be able to submit questions through the webcast. To access the webcast, please access the site at least 15 minutes prior to the scheduled start time in order to register, download, and install any necessary audio software.

To listen via teleconference:

US Participant dial-in: (877) 823-8690

International dial-in: (825) 312-2236

Conference ID: 8853923

To access a replay, which will be available until March 23, 2021:

US: (800) 585-8367

International: (416) 621-4642

Conference ID: 8853923

About Summit Materials, Inc.

Summit Materials is a leading vertically integrated materials-based company that supplies aggregates, cement, ready-mix concrete and asphalt in the United States and British Columbia, Canada. Summit is a geographically diverse, materials-based business of scale that offers customers a single-source provider of construction materials and related downstream products in the public infrastructure, residential and non-residential end markets. Summit has a strong track record of successful acquisitions since its founding and continues to pursue growth opportunities in new and existing markets. For more information about Summit Materials, please visit www.summit-materials.com.

Karli Anderson

Vice President Investor Relations

Summit Materials, Inc.

[email protected]

303-515-5152

KEYWORDS: United States North America Colorado

INDUSTRY KEYWORDS: Natural Resources Other Manufacturing Other Transport Engineering Logistics/Supply Chain Management Transport Mining/Minerals Manufacturing

MEDIA:

Logo
Logo

Tribune Publishing Reports Fourth Quarter and Full-Year 2020 Results

Digital content revenues increased 57.0%
year-over-year

Net increase in cash of $36.7 million

CHICAGO, March 04, 2021 (GLOBE NEWSWIRE) — Tribune Publishing Company (NASDAQ:TPCO) today announced financial results for the fourth quarter and full year ended December 27, 2020. Unless otherwise noted, amounts and disclosures throughout this earnings release relate to continuing operations and exclude BestReviews LLC.


2020 Full Year Highlights:

  • Net increase in cash of $36.7 million compared to December 29, 2019
  • Reduced lease obligations by $51.1 million, pension obligations by $3.5 million and a capital lease (classified as debt) by $6.9 million
  • Digital-only subscribers increased 30.5% to 436 thousand at the end of the fourth quarter 2020, up from 334 thousand at the end of the fourth quarter 2019
  • Digital content revenues increased $16.5 million or 57.0%
  • Total operating expenses decreased $138.1 million compared to 2019
  • Loss from continuing operations increased to $46.8 million from $7.1 million in 2019 as a result of a non-cash impairment charges of $78.7 million
  • Q4 income from continuing operations was $1.4 million, which was an increase of $10.0 million year over year

Terry Jimenez, Tribune Publishing CEO and President, said, “Thanks to the efforts of all our staff and business partners, we continue to make significant progress in mitigating the negative impact of the COVID-19 pandemic and positioning the Company for a successful future. In 2020, we grew our digital-only subscribers to 436 thousand, an increase of 30.5% from last year, and our digital-only revenue grew $16.5 million or 57.0% from the prior year. Due to our prudent focus on expenditures, we were also able to reduce operating expenses by $138.1 million or 14.5% compared to 2019. We also reduced more than $60 million of lease and pension obligations while substantially increasing cash. Despite the challenges the pandemic has presented, we were able to grow Adjusted EBITDA over both the third and fourth quarters compared to the prior-year periods, with fourth quarter Adjusted EBITDA of $27.3 million improving 7.3% over 2019.

Mr. Jimenez continued, “Although 2020 presented challenges for the Company, our employees, our customers and our communities, the steps we took over the course of the year to rationalize our cost structure, significantly reduce future obligations, pursue digital growth and invest in high quality content enabled Tribune to create a platform to succeed for years to come.”

“The journalism our newsrooms produce and the creative solutions our marketing teams deliver will remain core to our success. We are immensely proud of the positive impact our teams have in the communities we serve.”


2020 Fourth Quarter and Full Year Results


Fourth quarter 2020 total revenues were $192.7 million, down $46.7 million or 19.5% compared to $239.3 million for fourth quarter 2019. Advertising revenue continued to face challenges in all categories and declined by $32.7 million. Circulation revenues decreased 3.4% or $3.1 million in the three months ended December 27, 2020, compared to the same period for 2019. Home delivery decreased $6.0 million and single copy decreased $2.6 million. These declines were partially offset by an increase of $5.4 million in digital subscription revenue driven by an increased number of digital subscribers and higher subscription rates per subscriber. Other revenue declined $10.8 million or 25.3%, of which $2.5 million was related to a decline in transition services provided to the California properties compared to the prior year following the expiration of that agreement in the second quarter.

Total operating expenses, including depreciation and amortization, in the fourth quarter of 2020 were $190.9 million, down 22.7%, compared to $246.9 million in the fourth quarter of 2019. Total operating expenses for the full year decreased $138.1 million from the prior-year period. These decreases resulted from the Company’s ongoing strong cost management, including a focus on the reduction of fixed costs.

Income from continuing operations was $1.4 million in the fourth quarter of 2020, compared to a loss of $8.6 million in the fourth quarter of 2019, driven partially by an improvement in revenue declines compared to the prior 2020 quarters and aggressive cost management. For the full year, the Company reported a loss from continuing operations of $46.8 million compared to $7.1 million in 2019

Adjusted EBITDA was $27.3 million in the fourth quarter of 2020, an increase of $1.9 million compared to $25.5 million in the fourth quarter of 2019. Full-year adjusted EBITDA of $71.8 million decreased $14.5 million or 16.8% from 2019.

For the full year ended December 27, 2020, capital expenditures totaled $10.1 million. Cash balance at December 27, 2020, was $98.9 million, which excludes $29.9 million of restricted cash reflected in long-term assets and reflects an increase of $36.7 million from December 29, 2019.


Segment Results


The Company assesses its operating segments in accordance with ASC Topic 280, “Segment Reporting.” Beginning with the first quarter of fiscal 2020, Tribune began managing its business as one business and one reportable segment. The prior periods have been restated to reflect the change in reportable segments.


2021 Outlook


For first quarter of 2021, the Company expects total revenues of $170 million to $172 million and Adjusted EBITDA of $22 million to $23 million.


Pending Acquisition by Alden Global Capital


As announced on February 16, 2021, Tribune has entered into a definitive merger agreement under which affiliates of Alden Global Capital (“Alden”) will acquire all of the outstanding shares of Tribune common stock not currently owned by Alden for $17.25 per share in cash. The Company continues to expect the transaction to close in the second quarter of 2021, subject to, among other things, the expiration or termination of the applicable waiting periods under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, the approval of holders of two-thirds of Tribune common stock not owned by Alden, as well as other customary closing conditions. Upon completion of the transaction, Tribune will become a privately held company, and its common stock will no longer be listed on any public market.

Conference Call

In light of the pending transaction, the Company will not be hosting a conference call.


Non-GAAP Financial Information


Adjusted EBITDA, Adjusted Operating Expenses, Adjusted Income (Loss) from continuing operations attributable to Tribune common stockholders, and Adjusted Diluted EPS are not measures presented in accordance with generally accepted accounting principles in the United States (“U.S. GAAP” or “GAAP”) and Tribune Publishing’s use of the terms Adjusted EBITDA, Adjusted Operating expenses, Adjusted Income(Loss) from continuing operations attributable to Tribune common stockholders, and Adjusted Diluted EPS may vary from that of others in the Company’s industry. Adjusted EBITDA, Adjusted Operating Expenses, Adjusted Income (Loss) from continuing operations attributable to Tribune common stockholders, and Adjusted Diluted EPS should not be considered as an alternative to net income (loss), income from operations, operating expenses, net income (loss) per diluted share, revenues or any other performance measures derived in accordance with U.S. GAAP as measures of operating performance or liquidity. Further information regarding Tribune Publishing’s presentation of these measures, including a reconciliation of Adjusted EBITDA, Adjusted Operating Expenses, Adjusted Income (Loss) from continuing operations attributable to Tribune common stockholders and Adjusted Diluted EPS to the most directly comparable U.S. GAAP financial measure, is included below in this press release.


Cautionary Statements Regarding Forward-looking Statements


This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 that are based largely on our current expectations and reflect various estimates and assumptions by us. Forward-looking statements are subject to certain risks, trends and uncertainties that could cause actual results and achievements to differ materially from those expressed in such forward-looking statements. Such risks, trends and uncertainties, which in some instances are beyond our control, include, without limitation, the acquisition of the Company by Alden Global Capital may not be completed in a timely manner or at all; the effect of the novel coronavirus (“COVID-19”) and related governmental and economic responses; changes in advertising demand, circulation levels and audience shares; competition and other economic conditions; our ability to develop and grow our online businesses; changes in newsprint price and availability; our ability to maintain data security and comply with privacy-related laws; economic and market conditions that could impact the level of our required contributions to the defined benefit pension plans to which we contribute; decisions by trustees under rehabilitation plans (if applicable) or other contributing employers with respect to multiemployer plans to which we contribute which could impact the level of our contributions; our ability to maintain effective internal control over financial reporting; concentration of stock ownership among our principal stockholders whose interest may differ from those of other stockholders; and other events beyond our control that may result in unexpected adverse operating results. For more information about these and other risks see Item 1A (Risk Factors) of the Company’s most recent Annual Report on Form 10-K and in the Company’s other reports filed with the Securities and Exchange Commission.

The words “believe,” “expect,” “anticipate,” “estimate,” “could,” “should,” “intend,” “may,” “will,” “plan,” “seek” and similar expressions generally identify forward-looking statements. However, such words are not the exclusive means for identifying forward-looking statements, and their absence does not mean that the statement is not forward looking. Whether or not any such forward-looking statements, in fact occur will depend on future events, some of which are beyond our control. Readers are cautioned not to place undue reliance on such forward-looking statements, which are being made as of the date of this press release. Except as required by law, we undertake no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise.


About Tribune Publishing Company


Tribune Publishing Company (NASDAQ:TPCO) is a media company rooted in award-winning journalism.  Headquartered in Chicago, Tribune Publishing operates local media businesses in eight markets with titles including the Chicago TribuneNew York Daily NewsThe Baltimore Sun,  Hartford Courant, South Florida’s Sun Sentinel andOrlando Sentinel, Virginia’s Daily Press and The Virginian-Pilot, and The Morning Call of Lehigh Valley, Pennsylvania. In addition to award-winning local media businesses, Tribune Publishing operates Tribune Content Agency.

Tribune’s unique and valuable content across its brands have earned a combined 65 Pulitzer Prizes and are committed to informing, inspiring and engaging local communities. Tribune’s brands create and distribute content across our media portfolio, offering integrated marketing, media, and business services to consumers and advertisers, including digital solutions and advertising opportunities.


Investor Relations Contact:


Amy Bullis
Tribune Publishing Investor Relations
312.222.2102
[email protected]


Media Contact:


Max Reinsdorf
Tribune Publishing Media Relations
847.867.6294
[email protected]

Source: Tribune Publishing

Exhibits:
Consolidated Statements of Income (Loss)
Consolidated Balance Sheets
Non-GAAP Reconciliations – Income (Loss) from Continuing Operations to Adjusted EBITDA
Non-GAAP Reconciliations – Total Operating Expenses to Adjusted Operating Expenses
Non-GAAP Reconciliations – Net Income (Loss) from Continuing Operations Attributable to Tribune Common Stockholders to Adjusted Income (Loss) from Continuing Operations Attributable to Tribune Common Stockholders and Adjusted Diluted EPS

TRIBUNE PUBLISHING COMPANY

CONSOLIDATED STATEMENTS OF INCOME (LOSS)

(In thousands, except per share data)

(Unaudited)

Preliminary

    Three months ended   Year ended
    December 27, 2020   December 29, 2019   December 27, 2020   December 29, 2019
                 
Operating revenues   $ 192,650       $ 239,344       $ 746,250       $ 945,777    
                 
Operating expenses   190,936       246,949       812,774       950,897    
                 
Income (loss) from operations   1,714       (7,605 )     (66,524 )     (5,120 )  
                 
Interest income (expense), net   (382 )     21       (773 )     499    
Income (loss) on equity investments, net   (700 )     267       (817 )     (2,988 )  
Other income (expense), net   131       (220 )     1,368       45    
Income (loss) from continuing operations   763       (7,537 )     (66,746 )     (7,564 )  
Income tax expense (benefit)   (624 )     1,105       (19,930 )     (434 )  
Income (loss) from continuing operations   1,387       (8,642 )     (46,816 )     (7,130 )  
Plus: Earnings from discontinued operations, net of taxes   1,076       14,465       15,320       6,886    
Net income (loss)   2,463       5,823       (31,496 )     (244 )  
Less: Income attributable to noncontrolling interest   2,200       1,788       7,516       4,825    
Net income (loss) attributable to Tribune common stockholders   $ 263       $ 4,035       $ (39,012 )     $ (5,069 )  
                 
Basic net income (loss) attributable to Tribune per common share:                
Income (loss) from continuing operations   $ (0.02 )     $ (0.59 )     $ (1.50 )     $ (1.05 )  
Income (loss) from discontinued operations   0.03       0.41       0.42       0.19    
Basic net income (loss) attributable to Tribune per common share   $ 0.01       $ (0.18 )     $ (1.08 )     $ (0.85 )  
                 
Diluted net income (loss) attributable to Tribune per common share:                
Income (loss) from continuing operations   $ (0.02 )     $ (0.59 )     $ (1.50 )     $ (1.05 )  
Income (loss) from discontinued operations   0.03       0.41       0.42       0.19    
Diluted net income (loss) attributable to Tribune per common share   $ 0.01       $ (0.18 )     $ (1.08 )     $ (0.85 )  
                 
Weighted average shares outstanding                
Basic   36,547       36,038       36,456       35,810    
Diluted   36,781       36,038       36,456       35,810    
                 



TRIBUNE PUBLISHING COMPANY


CONSOLIDATED BALANCE SHEETS

(In thousands)

(Unaudited)

Preliminary

    December 27, 2020   December 29, 2019
Assets        
Current assets:        
Cash   $ 98,862     $ 54,840  
Accounts receivable, net   73,866     99,340  
Inventories   4,055     4,820  
Prepaid expenses   18,344     15,114  
Current assets related to discontinued operations   111,239     19,537  
Total current assets   306,366     193,651  
Property, plant and equipment, net   48,325     123,891  
Other assets        
Goodwill   28,146     30,624  
Intangible assets, net   50,148     61,517  
Software, net   17,503     20,736  
Lease right-of-use asset   36,705     99,480  
Restricted cash   29,925     37,290  
Equity investments   11,354     2,655  
Other long-term assets   19,682     17,713  
Assets related to discontinued operations       94,721  
Total other assets   193,463     364,736  
Total assets   $ 548,154      $ 682,278   
         
Liabilities and stockholders’ equity        
Current liabilities        
Accounts payable   $ 28,022     $ 43,674  
Employee compensation and benefits   33,495     36,238  
Deferred revenue   34,620     42,773  
Current portion of long-term lease liability   23,914     25,380  
Other current liabilities   23,329     24,412  
Current liabilities associated with discontinued operations   4,759     2,885  
Total current liabilities   148,139     175,362  
Non-current liabilities        
Long-term lease liability   49,182     98,847  
Pension and postretirement benefits payable   16,803     20,338  
Long-term debt       6,857  
Workers’ compensation, general liability and auto insurance payable   20,120     24,192  
Other obligations   12,508     8,355  
Total non-current liabilities   98,613     158,589  
Noncontrolling interest       63,501  
Stockholders’ equity   301,402     284,826  
Total liabilities and stockholders’ equity   $ 548,154      $ 682,278   



TRIBUNE PUBLISHING COMPANY


NON-GAAP RECONCILIATIONS

(In thousands) (Unaudited)

Preliminary

Reconciliation of Income (Loss) from Continuing Operations to
Adjusted EBITDA:

    Three months ended   Year ended
    Dec. 27, 2020   Dec. 29, 2019   % Change   Dec. 27, 2020   Dec. 29, 2019   % Change
Income (loss) from continuing operations   $ 1,387       $ (8,642 )     *   $ (46,816 )     $ (7,130 )     *
Income tax expense (benefit)   (624 )     1,105       *   (19,930 )     (434 )     *
Interest income (expense), net   382       (21 )     (1,919.0%)   773       (499 )     *
Loss (gain) on equity investments, net   700       (267 )     *   817       2,988       (72.7%)
Other income (expense), net   (131 )     220       *   (1,368 )     (45 )     *
Income (loss) from operations   1,714       (7,605 )     (122.5%)   (66,524 )     (5,120 )     *
Depreciation and amortization   7,088       11,657       (39.2%)   33,834       44,615       (24.2%)
Impairment   22,730       14,496       *   78,739       14,496       *
Restructuring and transaction costs (1)   (5,256 )     4,832       (208.8%)   20,556       19,191       7.1%
Stock-based compensation   1,064       2,105       (49.5%)   5,198       13,170       (60.5%)
Adjusted EBITDA   $ 27,340       $ 25,485       7.3%   $ 71,803       $ 86,352       (16.8%)

* Represents positive or negative change in excess of 100%

(1) – Restructuring and transaction costs include costs related to Tribune’s internal restructuring, such as severance, charges associated with vacated space, costs related to completed and potential acquisitions and a one-time charge related to the Consulting Agreement in 2018. See Note 7 for further information on the Consulting Agreement.

Adjusted EBITDA and Adjusted EBITDA margin

Adjusted EBITDA is a financial measure that is not calculated in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP” or “GAAP”). Management believes that because Adjusted EBITDA excludes (i) certain non-cash expenses (such as depreciation, amortization, impairment, stock-based compensation, and gain/loss on equity investments)and (ii) expenses that are not reflective of the Company’s core operating results over time (such as restructuring costs, including the employee voluntary separation program and gain/losses on employee benefit plan terminations, litigation or dispute settlement charges or gains, premiums on stock buybacks and transaction-related costs), this measure provides investors with additional useful information to measure the Company’s financial performance, particularly with respect to changes in performance from period to period.  The Company’s management uses Adjusted EBITDA (a) as a measure of operating performance; (b) for planning and forecasting in future periods; and (c) in communications with the Company’s Board of Directors concerning the Company’s financial performance. In addition, Adjusted EBITDA, or a similarly calculated measure, has been used as the basis for certain financial maintenance covenants that the Company was subject to in connection with certain credit facilities. Since not all companies use identical calculations, the Company’s presentation of Adjusted EBITDA may not be comparable to other similarly titled measures of other companies and should not be used by investors as a substitute or alternative to net income or any measure of financial performance calculated and presented in accordance with U.S. GAAP. Instead, management believes Adjusted EBITDA should be used to supplement the Company’s financial measures derived in accordance with U.S. GAAP to provide a more complete understanding of the trends affecting the business.

Although Adjusted EBITDA is frequently used by investors and securities analysts in their evaluations of companies, Adjusted EBITDA has limitations as an analytical tool, and investors should not consider it in isolation or as a substitute for, or more meaningful than, amounts determined in accordance with U.S. GAAP. Some of the limitations to using non-GAAP measures as an analytical tool are: they do not reflect the Company’s interest income and expense, or the requirements necessary to service interest or principal payments on the Company’s debt; they do not reflect future requirements for capital expenditures or contractual commitments; and although depreciation and amortization charges are non-cash charges, the assets being depreciated and amortized will often have to be replaced in the future, and non-GAAP measures do not reflect any cash requirements for such replacements.

The Company does not provide a reconciliation of Adjusted EBITDA guidance due to the inherent difficulty in forecasting and quantifying certain amounts that are necessary for such reconciliation, including adjustments that could be made for restructuring and transaction costs, stock-based compensation amounts and other charges reflected in our reconciliation of historic numbers, the amount of which, based on historical experience, could be significant.

TRIBUNE PUBLISHING COMPANY

NON-GAAP RECONCILIATIONS

(In thousands)

(Unaudited)

Preliminary

Reconciliation of Total Operating Expenses to Adjusted Operating Expenses:

Adjusted operating expenses consist of total operating expenses per the income statement, adjusted to exclude the impact of items listed in the Adjusted EBITDA non-GAAP reconciliation, the additional expenses related to the BestReviews disposition and the impact of the TSA expenses in 2019. Management believes that Adjusted operating expenses is informative to investors as it enhances the investors’ overall understanding of the financial performance of the Company’s business as they analyze current results compared to prior periods.

    Three months ended December 27, 2020   Three months ended December 29, 2019
    GAAP   Adjustments(1)   Adjusted Operating Expenses   GAAP   Adjustments(1)   Adjusted Operating Expenses
                         
Compensation           $ 72,632     $ (5,695 )     $ 66,937     $ 85,459     $ (3,196 )     $ 82,263  
Newsprint and ink           7,993           7,993     12,951           12,951  
Outside services           65,907     (620 )     65,287     86,115     (3,669 )     82,446  
Other operating expenses           14,586     10,507       25,093     36,271     (72 )     36,199  
Depreciation and amortization           7,088     (7,088 )         11,657     (11,657 )      
Impairment           22,730     (22,730 )         14,496     (14,496 )      
                         
Total operating expenses   $ 190,936     $ (25,626 )     $ 165,310     $ 246,949     $ (33,090 )     $ 213,859  

    Year ended December 27, 2020   Year ended December 29, 2019
    GAAP   Adjustments(1)   Adjusted Operating Expenses   GAAP   Adjustments(1)   Adjusted Operating Expenses
                         
Compensation           $ 303,027     $ (37,130 )     $ 265,897     $ 360,779     $ (22,975 )     $ 337,804  
Newsprint and ink           33,777     (63 )     33,714     56,785           56,785  
Outside services           267,644     (3,259 )     264,385     326,807     (8,621 )     318,186  
Other operating expenses           95,753     14,698       110,451     147,415     (765 )     146,650  
Depreciation and amortization           33,834     (33,834 )         44,615     (44,615 )      
Impairment           78,739     (78,739 )         14,496     (14,496 )      
                                
Total operating expenses   $ 812,774     $ (138,327 )     $ 674,447     $ 950,897     $ (91,472 )     $ 859,425  

(1) – Adjusted operating expenses consist of total operating expenses per the income statement, adjusted to exclude the impact of items listed in the Adjusted EBITDA non-GAAP reconciliation, the additional expenses related to the BestReviews disposition and the impact of the TSA expenses in 2019.

TRIBUNE PUBLISHING COMPANY

NON-GAAP RECONCILIATIONS

(In thousands)

(Unaudited)

Preliminary

Reconciliation of Net Income (Loss) from Continuing Operations Attributable to Tribune Common Stockholders to Adjusted Income (Loss) from Continuing Operations Attributable to Tribune Common Stockholders and Adjusted Diluted EPS:

Adjusted income (loss) from continuing operations attributable to Tribune common stockholders is defined as Net income (loss) from continuing operations attributable to Tribune common stockholders – GAAP excluding the adjustments for restructuring and transaction costs, net of the impact of income taxes.

Net income (loss) from continuing operations attributable to Tribune common stockholders – GAAP consists of Income (loss) from continuing operations per the Consolidated Statements of Income (Loss), less Income attributable to noncontrolling interests and the noncontrolling interest carrying value adjustment as set forth in the Earnings Per Share calculation in the Company’s Form 10-K.

Adjusted Diluted EPS computes Adjusted income (loss) from continuing operations attributable to Tribune common stockholders divided by diluted weighted average shares outstanding.

Management believes Adjusted income (loss) from continuing operations attributable to Tribune common stockholders and Adjusted Diluted EPS are informative to investors as they enhance investors’ overall understanding of the financial performance of the Company’s business as they analyze current results compared to future recurring projections.

    Three months ended
    December 27, 2020   December 29, 2019
    Earnings   Diluted EPS   Earnings   Diluted EPS
Net income (loss) from continuing operations attributable to Tribune common stockholders – GAAP           $ (813 )   $ (0.02 )   $ (21,097 )   $ (0.59 )
Adjustments to operating expenses, net of 27.8% tax                
Restructuring and transaction costs           (3,795 )   (0.10 )   21,549     0.60  
Adjusted income (loss) from continuing operations attributable to Tribune common stockholders – Non-GAAP   $ (4,608 )   $ (0.12 )   $ 452     $ 0.01  

    Year ended
    December 27, 2020   December 29, 2019
    Earnings   Diluted EPS   Earnings   Diluted EPS
Net loss from continuing operations attributable to Tribune common stockholders – GAAP           $ (54,654 )   $ (1.50 )   $ (37,475 )   $ (1.05 )
Adjustments to operating expenses, net of 27.8% tax                
Restructuring and transaction costs           14,841     0.41     13,856     0.39  
Adjusted income (loss) from continuing operations attributable to Tribune common stockholders – Non-GAAP   $ (39,813 )   $ (1.09 )   $ (23,619 )   $ (0.66 )



Myomo to Report Fourth Quarter and Full Year 2020 Financial Results on March 10, 2021

Myomo to Report Fourth Quarter and Full Year 2020 Financial Results on March 10, 2021

BOSTON–(BUSINESS WIRE)–Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that it will report financial results for the three months and year ended December 31, 2020 on March 10, 2021 after the market close.

The Company will host a conference call the same day, Wednesday, March 10, 2021 at 4:30 p.m. ET with prepared remarks by Paul R. Gudonis, chairman and chief executive officer, and David Henry, chief financial officer.

We encourage participants to pre-register for the conference call using the following link: https://dpregister.com/sreg/10152838/e3851573d0. Callers who pre-register will be given a conference passcode and unique PIN to gain immediate access to the call and bypass the live operator. Participants may pre-register at any time, including up to and after the call start time. Those without internet access or unable to pre-register may dial in by calling, 1-844-707-6932 (U.S.) or 1-412-317-9250 (International). A webcast of the call may also be accessed at Myomo’s Investor Relations page at http://ir.myomo.com/.

A replay of the webcast will be available beginning approximately one hour after the completion of the live conference call at http://ir.myomo.com/. A dial-in replay of the call will be available until March 24, 2021; please dial 1-877-344-7529 (U.S.) or 1-412-317-0088 (International) and provide the passcode #10152838.

About Myomo, Inc.

Myomo, Inc. is a wearable medical robotics company that offers improved arm and hand function for those suffering from neurological disorders and upper limb paralysis. Myomo develops and markets the MyoPro product line. MyoPro is a powered upper limb orthosis designed to support the arm and restore function to the weakened or paralyzed arms of patients suffering from CVA stroke, brachial plexus injury, traumatic brain or spinal cord injury, ALS or other neuromuscular disease or injury. It is currently the only marketed device that, sensing a patient’s own EMG signals through non-invasive sensors on the arm, can restore an individual’s ability to perform activities of daily living, including feeding themselves, carrying objects and doing household tasks. Many are able to return to work, live independently and reduce their cost of care. Myomo is headquartered in Cambridge, Massachusetts, with sales and clinical professionals across the U.S and representatives internationally. For more information, please visit www.myomo.com.

For Myomo:

[email protected]

Investor Relations:

Kim Sutton Golodetz

LHA Investor Relations

212-838-3777

[email protected]

Public Relations:

Kate McCann

Matter Communications

[email protected]

KEYWORDS: United States North America Massachusetts

INDUSTRY KEYWORDS: Technology Medical Devices Telecommunications Software Biotechnology Hardware Health General Health Data Management

MEDIA:

Logo
Logo

Puma Biotechnology to Present at the Barclays Global Healthcare Conference

Puma Biotechnology to Present at the Barclays Global Healthcare Conference

LOS ANGELES–(BUSINESS WIRE)–
Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that Alan H. Auerbach, Chairman, Chief Executive Officer, President and Founder of Puma, will provide an overview of the Company at the Barclays Global Healthcare Conference, which will be held virtually from March 9-11, 2021. Puma’s presentation will take place at 1:50 p.m. EST (10:50 a.m. PST) on Thursday, March 11, 2021.

A live webcast of the presentation will be available on the Company’s website at www.pumabiotechnology.com. The presentation will be archived on the website and available for 30 days.

About Puma Biotechnology

Puma Biotechnology, Inc. is a biopharmaceutical company with a focus on the development and commercialization of innovative products to enhance cancer care. Puma in-licenses the global development and commercialization rights to PB272 (neratinib, oral), PB272 (neratinib, intravenous) and PB357. Neratinib, oral was approved by the U.S. Food and Drug Administration in 2017 for the extended adjuvant treatment of adult patients with early stage HER2-overexpressed/amplified breast cancer, following adjuvant trastuzumab-based therapy, and is marketed in the United States as NERLYNX® (neratinib) tablets. In February 2020, NERLYNX was also approved by the FDA in combination with capecitabine for the treatment of adult patients with advanced or metastatic HER2-positive breast cancer who have received two or more prior anti-HER2-based regimens in the metastatic setting. NERLYNX was granted marketing authorization by the European Commission in 2018 for the extended adjuvant treatment of adult patients with early stage hormone receptor-positive HER2-overexpressed/amplified breast cancer and who are less than one year from completion of prior adjuvant trastuzumab-based therapy. NERLYNX is a registered trademark of Puma Biotechnology, Inc.

Alan H. Auerbach or Mariann Ohanesian, Puma Biotechnology, Inc., +1 424 248 6500

[email protected]

[email protected]

David Schull or Maggie Beller, Russo Partners, +1 212 845 4200

[email protected]

[email protected]

KEYWORDS: United States North America California

INDUSTRY KEYWORDS: Biotechnology Pharmaceutical Health Oncology

MEDIA:

Logo
Logo

Onconova Therapeutics to Provide Corporate Update and Full Year 2020 Financial Results

Company to Hold Conference Call and Webcast at 4:30 p.m. Eastern Time on Thursday, March 11, 2021

NEWTOWN, Pa., March 04, 2021 (GLOBE NEWSWIRE) — Onconova Therapeutics, Inc. (NASDAQ: ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products for patients with cancer, today announced that the Company will release its year-end 2020 financial results on Thursday, March 11, 2021, after the market closes. Management will host a conference call and live webcast at 4:30 p.m. ET on the same day to discuss these results and provide an update on its pipeline programs.

Interested parties who wish to participate in the conference call may do so by dialing (855) 428-5741 for domestic and (210) 229-8823 for international callers and using conference ID 3863774. Those interested in listening to the conference call live via the internet may do so by visiting the investors’ page of the company’s website at www.onconova.com and clicking on the webcast link.

A webcast replay will be available on the Onconova website for 90 days following the call by visiting the investor page of the company’s website at www.onconova.com

About Onconova Therapeutics, Inc.

Onconova Therapeutics is a clinical-stage biopharmaceutical company focused on discovering and developing novel products to treat cancer. The Company has proprietary targeted anti-cancer agents designed to disrupt specific cellular pathways that are important for cancer cell proliferation.

Onconova’s novel, proprietary multi-kinase inhibitor ON 123300 is planned to begin a dose-escalation and expansion Phase 1 trial in the U.S. in the first half of 2021, and a dose-escalation and expansion Phase 1 trial is currently underway in China.

Onconova’s product candidate oral rigosertib is currently in a dose-escalation and expansion Phase 1 investigator-initiated study targeting patients with KRAS+ lung adenocarcinoma in combination with nivolumab. In addition, Onconova has commenced preclinical work investigating rigosertib in COVID-19.

For more information, please visit www.onconova.com.

Contact information

Company Contact:

Avi Oler
Onconova Therapeutics, Inc.
267-759-3680
[email protected] 
https://www.onconova.com/contact/

Investor Contact:

LHA Investor Relations
Kim Sutton Golodetz
212-838-3777
[email protected]